Writing the NIH shared instrumentation grant (S10): Strategies for success

Scientific progress and breakthroughs today are often facilitated by the application of new technologies using high-end, cutting-edge instrumentation such as the new electron microscopes, which are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (NIH) funds millions of dollars to institutions and their federally funded investigators seeking high-end instruments that bring these resources as shared instruments to advance new discoveries. Specifically, the NIH’s High-End Instrumentation (HEI) Grant program (S10) encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of high-end, specialized, commercially available instruments or integrated systems that range from $600k to $2M. Such systems include but are not limited to mass spectrometers, nuclear magnetic resonance spectrometers, DNA and protein sequencers, electron microscopes, cell sorters, high-throughput robotic screening systems, and biomedical imagers.

In this webinar, you will learn:

The purpose and boundaries of the NIH S10 High-End Instrumentation and Shared Resource -Grant Programs and how to interpret the NIH Program Announcement
Specifics of Application Requirements: What goes in (and what does not) these grants.
Proven strategies for writing a successful S10 grant

About the presenter

Dr. Christopher C. Dant, Consultant, Medcom Consulting

Dr. Christopher Dant has over 40 years' experience first as medical researcher and as a medical writer and writing consultant in biopharmaceutical, government, and academic settings. He received his MA and PhD in genetics and molecular biology from Indiana University and University of Michigan and was a postdoctoral scholar at University of Vermont. He was formerly a senior writer in academic and pharmaceutical settings, a peer-reviewed medical journal editor, and is currently a consultant in producing grants at Stanford's Medical School. In 2005-2010, he established the Clinical Publications Division at Genentech in California. He had served on the faculty at Dartmouth Medical School and Norris Cotton Cancer Center and consults with Stanford Medical School and University of California at San Francisco. Dr. Dant worked through the NIH-NINDS as a peer review grant consultant. He lectures widely in academic and biopharma settings on NIH career and research grants, manuscript writing, and basic scientific writing for scientists.